跳至主要内容
临床试验/ITMCTR2200005701
ITMCTR2200005701招募中未知

Study on the clinical efficacy and mechanism of Sijun Wupi Decoction in the treatment of refractory ascites due to liver cirrhosis based on the spleen governing transportation and chemistry

Affiliated Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Treatment study

入排标准

年龄范围
18 至 ??(—)
性别
All

入选标准

  • (1) Meet the above-mentioned diagnostic criteria for refractory ascites due to liver cirrhosis;
  • (2) Aged over 18 years old;
  • (3) Sign the informed consent form.

排除标准

  • (1) The patient is under 18 years old;
  • (2) Patients with non-refractory ascites due to liver cirrhosis;
  • (3) Patients with hepatocarcinoma, cardiogenic, tuberculosis and renal ascites;
  • (4) Patients with compensatory cirrhosis and without ascites;
  • (5) Patients with severe diseases of cardiovascular, kidney, hematopoietic system, nervous system, tumor disease and mental illness;
  • (6) Patients with gastrointestinal bleeding;
  • (7) Pregnant or lactating women.

研究者

发起方
Affiliated Hospital of Traditional Chinese Medicine

相似试验